Novogen Limited And Feinstein Institute Join Forces To Find Effective Treatments For Brain Cancer

At the heart of the collaboration is the Company's super-benzopyran drug technology platform, distinguished by its ability to kill the full spectrum of cells within a tumor including both rapidly- and slowly-dividing cancer cells .

http://ift.tt/1CWgAjS